Medifast (MED) Misses Q4 EPS by 8c, Guidance Mixed
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Needham Starts NeoVolta (NEOV) at Buy
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Medifast, Inc. Announces Fourth Quarter and Fiscal Year 2014 Financial Results
March 12, 2015 4:05 PM EDTOWINGS MILLS, Md., March 12, 2015 /PRNewswire/ --Â Medifast, Inc. (NYSE: MED), a leading United States manufacturer and provider of clinically proven weight-loss and healthy living products and programs, today reported financial results for the fourth quarter and fiscal year ended December 31, 2014.
"In 2014 we took decisive action and set future strategic direction to better position our business for long-term profitability and growth," said Michael C. MacDonald, Medifast Chairman and Chief Executive Officer. "We are confident that the strategic actions we've undertaken... More
